Us Congress 2023-2024 Regular Session

Us Congress House Bill HB8570

Introduced
5/24/24  
Refer
5/24/24  

Caption

SIDDI Act of 2024 Safe In-Home Drug Disposal Initiative Act of 2024

Impact

The passage of HB 8570 is expected to significantly impact state laws relating to pharmaceutical care by facilitating the establishment of structured programs that promote safe medication practices. The bill provides a structured framework for how states can apply for and administer these grants while ensuring that pharmacies participate effectively in the program. As part of the initiative, selected pharmacies will have the responsibility to implement unique disposal systems that adhere to safety and environmental standards, which enhances public health efforts relating to drug misuse and environmental hazards caused by improper disposal.

Summary

House Bill 8570, known as the Safe In-Home Drug Disposal Initiative Act of 2024, is aimed at establishing a pharmacy program that provides grants for safe in-home drug disposal and practical medication safety education. The bill mandates the Secretary of Health and Human Services to award grants to states for targeted State demonstration initiatives (TSDIs) aimed at reimbursing licensed pharmacies for providing in-home drug disposal systems and medication safety education to eligible patients. This initiative seeks to address the ongoing opioid crisis by ensuring that patients, particularly those at risk for opioid-related overdoses, have safe methods for disposing of their unused medications and receive proper education on medication safety.

Contention

Notable points of contention surrounding HB 8570 include concerns about the effectiveness and implementation of the proposed programs by the states. Critics might question whether granting states the autonomy to design and administer these programs will lead to equitable access for all eligible patients, particularly in underserved areas. Furthermore, there may be debate over the adequacy of funding provided under the bill, with an authorization of $56 million for fiscal years 2025 through 2029, raising concerns about whether it will be sufficient to cover the costs associated with developing and maintaining these disposal programs effectively.

Companion Bills

No companion bills found.

Similar Bills

CA AB913

Pharmacy benefit managers.

CA SB362

Chain community pharmacies: quotas.

LA HB432

Provides for the regulation of pharmacy services administrative organizations (OR +$88,000 SG EX See Note)

MS HB1125

Pharmacy services; prohibit insurers and PBMs from requiring persons to obtain exclusively through pharmacies that they own.

LA HB387

Provides for the regulation of pharmacy services administrative organizations

CA AB401

Pharmacy: remote dispensing site pharmacy: telepharmacy: shared clinic office space.

CA AB690

Pharmacies: relocation: remote dispensing site pharmacy: pharmacy technician: qualifications.

MS HB1119

Pharmacy benefit managers; revise provisions related to.